Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2022

View Archived Issues

Deep immunophenotyping study characterizes advanced immune aging in individuals with Down syndrome

Co-stimulation with CD81 promotes CAR T-cell transduction toward naive T cells

Meta-analysis reveals candidate variants associated with brain traits

Researchers present preclinical model of ALS

New T-type calcium channel blockers identified at Sumitomo Dainippon Pharma

University of Tokyo discloses BDNF/NT-3 growth factor receptor activators

Enanta Pharmaceuticals presents compounds for influenza, RSV infections

Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors

New plasma kallikrein inhibitors identified at Merck Sharp & Dohme

Novel preclinical models of invasive papillary cholangiocarcinoma

Study links mycobiome, IL-33, tumor growth in pancreatic cancer

LISCure and Scripps collaborate on bacteria-mediated immuno-oncology candidates for cancer

Researchers present single-cell atlas of the normal and malformed brain vasculature

Novel AH:CpG-adjuvanted RBD vaccine with promising efficacy in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...